论文部分内容阅读
目的探讨米非司酮联合米索前列醇在中期妊娠中的应用。方法回顾分析320例患者的临床资料。结果口服米非司酮后,首次阴道给米索前列醇后24 h内排除妊娠产物者190例,首次阴道给药米索前列醇后48 h内排出妊娠产物者125例,首次阴道给米索前列醇后48 h内无流产者5例。结论米非司酮配伍米索前列醇给药在中期引产具有痛苦小、成功率高、副作用小等优点,值得应用。
Objective To investigate the application of mifepristone and misoprostol in mid-term pregnancy. Methods The clinical data of 320 patients were retrospectively analyzed. Results After oral administration of mifepristone, the first vaginal administration of misoprostol within 24 h after exclusion of pregnancy in 190 cases, the first vaginal administration of misoprostol within 48 h after the discharge of the product of pregnancy in 125 cases, the first vaginal administration of misoprostol Prothrombin within 48 h after abortion in 5 cases. Conclusion Mifepristone with misoprostol administered in the mid term induction of labor has the advantages of small pain, high success rate, small side effects, it is worth applying.